Assignee
SHANGHAI INST MATERIA MEDICA CAS
CN·75 granted patents·55 pending applications·39 citations·filing 2013–2025
Top patents by PatentIndex Score
130 records- 0188US9724352B2Pyrrolo[2,1-F[1,2,4]triazine compounds, preparation methods and applications thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2016·Granted Aug 8, 2017·5 cites·18 claims
- 0286US9447101B2Pyrrolo[2,1-f][1,2,4]triazine compound, and preparation method and application thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2013·Granted Sep 20, 2016·6 cites·11 claims
- 0385US12351599B2Antiviral application of nucleoside analog or combination formulation containing nucleoside analogSHANGHAI INST MATERIA MEDICA CAS·Filed 2023·Granted Jul 8, 2025·1 cites·19 claims
- 0483US11919923B2Antiviral application of nucleoside analog or combination formulation containing nucleoside analogSHANGHAI INST MATERIA MEDICA CAS·Filed 2021·Granted Mar 5, 2024·1 cites·25 claims
- 0581US12065447B2Heterocyclic amide for inhibiting RIP1 kinase and uses thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Granted Aug 20, 2024·1 cites·9 claims
- 0681US10829491B2Pyrimido[5,4-B]indolizine or pyrimido[5,4-B]pyrrolizine compound, preparation method and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2017·Granted Nov 10, 2020·3 cites·8 claims
- 0775US11078188B2Dihydroquinoxaline bromodomain recognition protein inhibitor, preparation method and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2018·Granted Aug 3, 2021·2 cites·11 claims
- 0875US10280146B2Pyrimidone compounds used as Lp-PLA2 inhibitors and pharmaceutical compositions thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2015·Granted May 7, 2019·2 cites·6 claims
- 0974US12240841B2FXR small molecule agonist and preparation method therefor and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2020·Granted Mar 4, 2025·1 cites·15 claims
- 1073US9751882B2Diaryl[A, G]quinolizidine compound, preparation method therefor, pharmaceutical composition, and uses thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2013·Granted Sep 5, 2017·5 cites·5 claims
- 1171US11498927B2Heterocyclic amide for inhibiting RIP1 kinase and uses thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2019·Granted Nov 15, 2022·2 cites·9 claims
- 1271US10961278B2Vancomycin derivative, preparation method, pharmaceutical composition and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2017·Granted Mar 30, 2021·1 cites·10 claims
- 1371US9637454B2Fluorine substituted cyclic amine compounds and preparation methods, pharmaceutical compositions, and uses thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2013·Granted May 2, 2017·2 cites·19 claims
- 1470US10618900B25-aromatic alkynyl substituted benzamide compound and preparation method, pharmaceutical composition, and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2016·Granted Apr 14, 2020·1 cites·17 claims
- 1567US11555009B22-(substituted benzene matrix) aromatic formate FTO inhibitor, preparation method therefor, and applications thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2018·Granted Jan 17, 2023·1 cites·16 claims
- 1666US11013745B2Triazolopyrimidine, triazolopyridine compounds, and the composition thereof for treating PRC2-mediated diseasesSHANGHAI INST MATERIA MEDICA CAS·Filed 2018·Granted May 25, 2021·1 cites·18 claims
- 1765US9796732B2Pyridopyrimidine or pyrimidopyrimidine compound, prepration method, pharmaceutical composition, and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2015·Granted Oct 24, 2017·1 cites·13 claims
- 1865US9533965B22-arylbenzofuran-7-formamide compounds, preparation method and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2013·Granted Jan 3, 2017·1 cites·8 claims
- 1964US10059694B22-aminopyrimidine compound and pharmaceutical composition and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2015·Granted Aug 28, 2018·1 cites·15 claims
- 2063US2025313539A1Alpha, Beta-UNSATURATED AMIDE COMPOUND, AND PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOFSHANGHAI INST MATERIA MEDICA CAS·Filed 2023·Application pending·0 cites
- 2163US2025340581A1Paeoniflorin monohydrate crystal form a, preparation method therefor, and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2025·Application pending·0 cites
- 2263US2025340545A1Tetrahydroisoquinoline compound, preparation method therefor, pharmaceutical composition containing said compound, and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2023·Application pending·0 cites
- 2362US9914707B2Naphthylamide compound, preparation method and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2015·Granted Mar 13, 2018·1 cites·20 claims
- 2462US2026053792A1Polysubstituted tetrahydroisoquinoline compounds, method for preparing same, pharmaceutical composition thereof, and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2023·Application pending·0 cites
- 2562US2025066359A1Somatostatin receptor subtype 5 antagonists, and pharmaceutical composition and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Application pending·0 cites
- 2661US2025345444A1Cleavable fragment directed by affinity fragment, design and synthesis thereof, and use thereof in preparation of site-directed drug conjugateSHANGHAI INST MATERIA MEDICA CAS·Filed 2023·Application pending·0 cites
- 2760US10787422B2Pyrimidone compounds used as Lp-PLA2 inhibitors and pharmaceutical compositions thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2019·Granted Sep 29, 2020·0 cites·8 claims
- 2860US2025090547A1Epa-ee lipid nanocomposite, formulation thereof, preparation method therefor, and application thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2023·Application pending·0 cites
- 2959US11384073B2Maleate salt of benzothiophene compound, crystalline form thereof, and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2020·Granted Jul 12, 2022·0 cites·14 claims
- 3059US11192916B2Pentacyclic triterpene compound and preparation method therefor, and pharmaceutical composition and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2018·Granted Dec 7, 2021·0 cites·4 claims
- 3159US2025145564A1Sulfonylurea compound, preparation method therefor, and application thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Application pending·0 cites
- 3259US2024351966A1Class of alkylphenol compounds and preparation method thereforSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Application pending·0 cites
- 3359US2024197900A1Disaccharide linker, disaccharide-small molecule drug conjugate and sugar chain fixed-point antibody-drug conjugate, and preparation method therefor and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Application pending·0 cites
- 3458US2025197503A1ANTI-HUMAN PD-Ll AND TLR7 DOUBLE-TARGETING NANOBODY CONJUGATE DRUG AND USE THEREOF IN RESISTING TUMORSHANGHAI INST MATERIA MEDICA CAS·Filed 2023·Application pending·0 cites
- 3558US2024261391A1Tlr7 agonist conjugated peptide-based novel coronavirus nanoemulsion vaccine and preparation thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Application pending·0 cites
- 3657US11434226B2Salt and polymorph of benzopyrimidinone compound and pharmaceutical composition and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2020·Granted Sep 6, 2022·0 cites·4 claims
- 3757US10611774B2Salt form of DPPIV inhibitor and preparation method thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2017·Granted Apr 7, 2020·0 cites·18 claims
- 3857US2025223599A1Preparation and anti-tumor application of gene therapy vector interfering cklf-like marvel transmembrane domain-containing protein 6 (cmtm6) expressionSHANGHAI INST MATERIA MEDICA CAS·Filed 2023·Application pending·0 cites
- 3957US2025122148A1High-selectivity kcnq4 potassium channel agonist, preparation method therefor and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2023·Application pending·0 cites
- 4057US2025042862A1Aromatic heterocyclic compound and application thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Application pending·0 cites
- 4157US2023301947A1Compound for preventing and treating psychiatric disorders and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2021·Application pending·0 cites
- 4257US2025009871A1Application of novel coronavirus vaccine peptide and nanoemulsion preparation thereof in prevention of novel coronavirus wild and mutant strainsSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Application pending·0 cites
- 4356US2025073249A1Steroid compound, and preparation method therefor and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2023·Application pending·0 cites
- 4456US2024262860A1Pentacyclic triterpenoid glycoside compound, and preparation method therefor and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2021·Application pending·0 cites
- 4556US2025270202A1Substituted 4-aminoisoindoline compound, preparation method therefor, pharmaceutical composition thereof, and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2023·Application pending·0 cites
- 4656US2025282812A1Antiviral nucleoside analogue, and pharmaceutical composition and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2023·Application pending·0 cites
- 4755US2025059219A1Lignan derivative, preparation method therefor and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Application pending·0 cites
- 4855US2024351986A1Urea compound containing 2-heteroaromatic ring substitution, preparation method therefor and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Application pending·0 cites
- 4955US2024270753A1Heterocyclic compound for inhibiting shp2 activity, preparation method therefor and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Application pending·0 cites
- 5054US12384795B2Pyrimido[5,4-b]pyrrolizin compound, optical isomer thereof, preparation method therefor and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2020·Granted Aug 12, 2025·0 cites·14 claims
Showing the top 50 of 130 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SHANGHAI INST MATERIA MEDICA CAS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →